Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto, T Kikuchi… - Clinical and …, 2019 - Springer
… a standardized commercial ELISA (Euroimmun, Germany). … of our in-house ELISA for
measurement of circulating PLA2R … obtained with the standardized commercial ELISA. The PLA2R …

Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study

SA Timmermans, JGMC Damoiseaux… - American journal of …, 2014 - academic.oup.com
… demonstrated to be very specific for idiopathic membranous nephropathy (MN). We studied
a novel enzyme-linked immunosorbent assay (ELISA) and compared results with results …

Validation of a phospholipase A2 receptor antibody ELISA in an Australian cohort with membranous glomerulonephritis

L Ong, R Silvestrini, J Chapman, DA Fulcher, MW Lin - Pathology, 2016 - Elsevier
… to validate the commercial PLA2R Ab ELISA in an Australian cohort with biopsy proven
membranous glomerulonephritis, to compare the performance of this ELISA against the IIFT, and …

[HTML][HTML] Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy

C Zaghrini, B Seitz-Polski, J Justino, G Dolla, C Payre… - Kidney International, 2019 - Elsevier
… as biomarkers to classify membranous nephropathy (MN) and … found a significant correlation
between ELISA and IIFT titers. … We conclude that the novel anti-THSD7A ELISA can be used …

Comparison of 2 Anti-PLA2R Immunoassays for the Diagnosis of Primary Membranous Nephropathy

W Li, Y Guo, Z Zhang, F Zhang, X Liu, X Ji… - Laboratory …, 2018 - academic.oup.com
… We used a commercial quantitative ELISA assay (EUROIMMUN AG) for the IgG-specific
isotype of anti-PLA 2 R, according to manufacturer instructions. In brief, serum specimens were …

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Y Katsumata, Y Okamoto, T Moriyama… - Immunological …, 2020 - Taylor & Francis
… -linked immunosorbent assay (ELISA) for the quantification of … of our project, a commercial
solid-phase direct ELISA kit was … this novel ELISA kit and compare it with our cell-based ELISA

Membranous nephropathy: a journey from bench to bedside

JM Francis, LH Beck Jr, DJ Salant - American Journal of Kidney Diseases, 2016 - Elsevier
ELISA. As illustrated in Fig 2, compared with the Western blot assay for anti-PLA 2 R, the
commercial IIFA and ELISA … glomerular disease, although the ELISA is somewhat less sensitive …

[HTML][HTML] Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience

B Porcelli, A Guarnieri, F Ferretti, G Garosi… - Journal of …, 2021 - Springer
… Taken together, these data show that while the commercial ELISA has the highest specificity
at 14 RU/ml, optimal sensitivity is achieved at a lower cut-off, around 2.7 RU/ml which …

[HTML][HTML] Towards optimizing use of PLA2R antibody testing in membranous nephropathy

JJ Hogan, J Zee, LH Beck - Journal of Nephrology, 2021 - Springer
… have shown that using a much lower ELISA cutoff (2–3 RU/… test characteristics of the
commercial ELISA for PLA2R-Ab in … -Ab ELISA were calculated and an optimal ELISA threshold for …

Characterization of autoantibodies in primary membranous nephropathy and their clinical significance

RAK Stahl, L Reinhard, E Hoxha - Expert Review of Clinical …, 2019 - Taylor & Francis
ELISA, the IIFT may again be applied for follow-up testing, once antibodies are no longer
detectable with an ELISA, … However, no commercial ELISA is available yet. Thus, similarly as for …